Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NetEase ADR | NTES | Jan 10, 2025 | 91.11 | -1.27 |
Netflix | NFLX | Jan 10, 2025 | 837.69 | -4.26 |
NETGEAR | NTGR | Jan 10, 2025 | 26.28 | -2.49 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Jan 10, 2025 | 44.66 | -1.00 |
NetScout Systems | NTCT | Jan 10, 2025 | 21.32 | -2.02 |
NETSOL Technologies | NTWK | Jan 10, 2025 | 2.65 | -1.85 |
Netstreit | NTST | Jan 10, 2025 | 13.64 | -0.58 |
Network-1 Technologies | NTIP | Jan 10, 2025 | 1.42 | -0.70 |
Neuberger Berman | NML | Jan 10, 2025 | 8.91 | -0.67 |
Neuberger Berman High Yield Strategies Fund | NHS | Jan 10, 2025 | 7.61 | -0.85 |
Neuberger Berman Municipal Fund | NBH | Jan 10, 2025 | 10.20 | -0.83 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Jan 10, 2025 | 12.81 | -1.99 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Jan 10, 2025 | 3.51 | -1.13 |
NeueHealth | NEUE | Jan 10, 2025 | 7.33 | -1.21 |
Neumora Therapeutics | NMRA | Jan 10, 2025 | 2.21 | -6.75 |
Neuphoria Therapeutics | NEUP | Jan 10, 2025 | 3.20 | 0.00 |
Neuraxis | NRXS | Jan 10, 2025 | 2.49 | 0.00 |
Neurobo Pharmaceuticals | NRBO | Jan 10, 2025 | 2.36 | 0.00 |
Neurocrine Biosciences | NBIX | Jan 10, 2025 | 140.90 | +1.58 |
Neurogene | NGNE | Jan 10, 2025 | 19.58 | -8.89 |
NeuroMetrix | NURO | Jan 10, 2025 | 3.97 | -1.73 |
Neuronetics | STIM | Jan 10, 2025 | 1.71 | +14.00 |
NeuroOne | NMTC | Jan 10, 2025 | 1.13 | +4.74 |
Neuropace | NPCE | Jan 10, 2025 | 11.94 | -0.58 |
NeuroSense Therapeutics | NRSN | Jan 10, 2025 | 1.04 | -6.97 |
Nevro | NVRO | Jan 10, 2025 | 3.29 | -5.73 |
New America High Income Fund | HYB | Jan 10, 2025 | 8.23 | +0.18 |
New Century Logistics (BVI) Limited - Ordinary Shares | NCEW | Jan 10, 2025 | 2.24 | 0.00 |
New Concept Energy | GBR | Jan 10, 2025 | 1.19 | -4.80 |
New England Realty Associates LP Unit A | NEN | Jan 10, 2025 | 83.14 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.